Domov › Nemalobunkový karcinóm pľúc › Michigan › Ann Arbor
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Ann Arbor, MI
26 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Ann Arbor a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- a 4 ďalších
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- a 3 ďalších
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- a 2 ďalších
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Prebieha náborFáza 3
- Trinity Health Ann Arbor Hospital, Ann Arbor
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- University of Michigan Health System, Ann Arbor
- Trinity Health St Joseph Mercy Ann Arbor, Ypsilanti · 7 míľ odtiaľ
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- a 4 ďalších
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 1
- University of Michigan Health Systems, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Prebieha náborFáza 1/2
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Prebieha náborFáza 3
- Clinical Study Site, Ann Arbor
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- University of Michigan, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Prebieha náborFáza 1
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- University of Michigan, Ann Arbor
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Prebieha náborFáza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor ( Site 9552), Ypsilanti · 7 míľ odtiaľ
Gilteritinib for the Treatment of ALK NSCLC
Prebieha náborFáza 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Prebieha náborFáza 1
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- a 4 ďalších
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- a 1 ďalších
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- a 4 ďalších
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Prebieha náborFáza 1/2
- University of Michigan, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Repositioning Immunotherapy in VetArans With Lung Cancer
Prebieha náborFáza 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- University of Michigan (Data Collection Only), Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Prebieha nábor
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Prebieha náborFáza 1/2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Ann Arbor
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Ann Arbor
- Rakovina prsníka27 štúdií
- Rakovina prostaty27 štúdií
- Rakovina (všetky typy)25 štúdií
- Rakovina pľúc23 štúdií
- Kolorektálny karcinóm23 štúdií
- Srdcové zlyhanie22 štúdií
- Akútna myeloidná leukémia17 štúdií
- Kardiovaskulárne ochorenia16 štúdií
- Rakovina pankreasu14 štúdií
- Melanóm12 štúdií
- Cievna mozgová príhoda12 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku12 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.